Related Experiment Videos
Cholesterol reduction following health screening in general practice
Helle Kanstrup1, Jens Refsgaard, Marianne Engberg
1Department of General Practice, University of Aarhus, Denmark. H.Kanstrup@dadlnet.dk
Scandinavian Journal of Primary Health Care
|February 5, 2003
Summary
Health screening and discussions significantly lowered plasma cholesterol in a 5-year study. High-risk individuals experienced the most substantial cholesterol reduction, improving cardiovascular health outcomes.
Area of Science:
- Public Health
- Preventive Medicine
- Cardiovascular Health
Background:
- Elevated plasma cholesterol is a significant risk factor for cardiovascular disease.
- General practice settings offer opportunities for population-based health interventions.
- Early detection and management of high cholesterol are crucial for preventing adverse cardiovascular events.
Purpose of the Study:
- To assess the impact of health screening and discussions on plasma cholesterol levels.
- To evaluate the effectiveness of general practice-based interventions in modifying cholesterol.
- To identify specific population subgroups that benefit most from such interventions.
Main Methods:
- A 5-year, randomized, prospective, population-based study.
- Involved general practitioners (GPs) and a random sample of adults aged 30-49.
- Participants were allocated to intervention or control groups, with plasma cholesterol as the primary outcome measure.
Main Results:
- Plasma cholesterol levels were significantly lower in intervention groups compared to the control group after 5 years.
- The most pronounced decrease (0.5 mmol/l) was observed in subjects at high cardiovascular risk.
- A 37% reduction in high-risk individuals (9.8% vs 6.2%) with cholesterol > 7 mmol/l was noted in intervention groups.
Conclusions:
- Health checks and discussions in general practice demonstrably reduce plasma cholesterol.
- Individuals at high cardiovascular risk showed the most significant improvements in cholesterol levels.
- Primary care interventions are effective in managing plasma cholesterol and potentially reducing cardiovascular risk.